Cartesian Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	303	461	107	-	-
Market Cap Growth	-43.90%	330.61%	-	-	-
Enterprise Value	158	256	123	-	-
Last Close Price	11.71	17.91	20.68	-	-
PS Ratio	282.06	11.84	4.12	-	-
PB Ratio	-	-67.74	-0.77	-	-
EV/Sales Ratio	153.52	6.58	4.75	-	-
Debt / Equity Ratio	-5.28	-2.06	-0.08	0.40	0.18
Debt / EBITDA Ratio	-	-	-	2.01	-
Asset Turnover	0.00	0.11	0.11	1.26	-
Quick Ratio	13.11	9.29	1.26	5.76	6.38
Current Ratio	13.33	9.43	1.33	5.91	6.42
Return on Equity (ROE)	-	-	-	70.21%	-
Return on Assets (ROA)	-13.65%	-6.00%	-19.75%	10.35%	-
Return on Capital (ROIC)	-	-	-3021.69%	12.98%	-
Return on Capital Employed (ROCE)	-	-	-	10.30%	-
Earnings Yield	-11.91%	-16.80%	-205.34%	-	-
FCF Yield	-14.62%	-7.11%	-48.01%	-	-
Buyback Yield / Dilution	-203.30%	-235.72%	-6.33%	-27.59%	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q